Credit Suisse Remains a Hold on Elanco Animal Health Inc (ELAN)

By Ryan Adsit

In a report released yesterday, Erin Wright from Credit Suisse maintained a Hold rating on Elanco Animal Health Inc (ELANResearch Report), with a price target of $36. The company’s shares closed yesterday at $31.76.

According to TipRanks.com, Wright is ranked #551 out of 5105 analysts.

Elanco Animal Health Inc has an analyst consensus of Moderate Buy, with a price target consensus of $35.50.

See today’s analyst top recommended stocks >>

The company has a one-year high of $37.61 and a one-year low of $30.10. Currently, Elanco Animal Health Inc has an average volume of 2.11M.

Based on the recent corporate insider activity of 23 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ELAN in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It operates through the following categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.